Table 4.
Drug loading and encapsulation efficiency of NPs (n = 6)
| Polymer | CB13 (%w/w) initial | EE ± SD (%) | CB13 loading ± SD (%w/w) |
|---|---|---|---|
| R502 | 6 | 89.61 ± 0.25 | 6.16 ± 1.12 |
| 10 | 82.26 ± 3.73 | 12.22 ± 6.69 | |
| 20 | 70.75 ± 4.82 | 16.26 ± 0.97 | |
| R502H | 6 | 80.74 ± 2.95 | 4.84 ± 1.12 |
| 10 | 77.094 ± 3.01 | 6.71 ± 2.30 | |
| 20 | 67.709 ± 1.98 | 15.64 ± 3.01 | |
| R504 | 6 | 75.44 ± 2.79 | 16.90 ± 1.10 |
| R504H | 6 | 71.53 ± 3.06 | 16.11 ± 2.24 |
| R752S | 6 | 83.21 ± 1.57 | 18.75 ± 3.05 |
Abbreviations: NPs, nanoparticles; R, Resomer; CB13, 1-Naphthalenyl[4-(pentyloxy)-1-naphthalenyl]methanone; EE, encapsulation efficiency; SD, standard deviation.